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a b s t r a c t
IgA vasculitis (IgAV) is a leukocytoclastic vasculitis and characterized by involvement of
small vessels in skin, gastrointestinal system, joints, kidneys, and less frequently other
organs. It is the commonest vasculitis in childhood and etiology is not completely known.
Neurological manifestations of IgAV are very rare and usually seen in patients with severe
hypertension or as an uncommon feature such as peripheral neuropathy. Posterior revers-
ible encephalopathy syndrome (PRES) is a clinic-radiologic entity characterized with tem-
porary vasogenic edema developing typically in posterior circulation of the brain and has
been reported as a rare manifestation of IgAV. In this paper, a PRES case of 14-year-old male
with IgAV is reported and etiopathogenesis was discussed with literature. Diagnosis was
made by magnetic resonance imaging because of the existence of neurological symptoms
(headache and visual loss) during the course of disease. His radiological ﬁndings have
resolved with therapy. Although neurological involvement is a rare manifestation in IgAV,
we recommend magnetic resonance imaging in such patients for diagnosis and evaluation
of complications.
© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Neurological Society.
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IgA vasculitis (IgAV) is the most frequent vasculitis of
childhood with an incidence of 10–20/100 000/year [1]. IgA
vasculitis, formerly called Henoch-Schönlein purpura, is an
immune complex vasculitis predominantly affecting small
vessels. It is characterized by non-thrombocytopenic purpura,
arthritis, arthralgia, and renal involvement, stomachache and* Corresponding author.
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0028-3843/© 2017 Published by Elsevier Sp. z o.o. on behalf of Polish Ngastrointestinal hemorrhage. While, as seen less frequently,
every organ system can be involved. Although the etiopatho-
genesis is not understood completely, various factors such as
infectious agents, vaccines, medicines, nutrients, and insect
bites have been reported that could trigger the pathogenetic
mechanism [1,2].
IgAV is usually a self-limited disease lasting an average of 4
weeks [1]. More commonly, renal involvement is a mild
disorder with good prognosis and is presenting with onlyhotmail.com (A. Yavuz), ayse.ars12@gmail.com (A. Arslan), abdur-
eurological Society.
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or renal function impairment is rarely seen in IgA vasculitis
(IgAV) patients [2].
Posterior reversible encephalopathy syndrome (PRES) has
been ﬁrstly identiﬁed by Hinchey et al. in 1996 and ‘‘reversible
posterior leukoencephalopathy syndrome’’, ‘‘hypertensive
encephalopathy’’, ‘‘reversible posterior cerebral edema syn-
drome’’ and ‘‘posterior reversible leukoencephalopathy’’ are
all terms that have been used to deﬁne a clinical and radiologic
syndrome characterized by headache, alteration of conscious-
ness, seizures, and visual disturbance associated with revers-
ible cerebral vasogenic edema [3–6]. Main underlying causes in
children are hypertensive encephalopathy, haemolytic uremic
syndrome, treatment with immunosuppressive drugs, acute/
chronic renal failure and lupus nephritis [3,5,7].
In this paper, we present a case, in which skin, kidney,
gastrointestinal system involvement have been observed.
PRES has developed in association with IgAV and diagnosed by
neuroimaging. Abnormal radiological ﬁndings disappeared on
MRI soon after starting treatment.
2. Case report
A 14-year-old male with a two weeks history of purpuric rush,
arthralgia, nausea and severe abdominache was admitted to
our hospital. The previous medical history was unremarkable.
Physical examination on arrival revealed blood pressure (BP)
100/60 mmHg, typical palpable purpura on both lower extrem-
ities and arthritis ﬁndings on both ankles. His weight was 56 kg
(50–75 percentiles) and height 160 cm (25–50 percentiles). No
fever, pretibial edema or rebaund on abdominal examination
were noted. On laboratory investigation; hemoglobin was
13.9 g/dl, leukocyte count 19 330/mm3 and thrombocyte
209 000/mm3. Serum sodium was 138 mEq/L (N = 136–146),
potassium 4.8 mEq/L (N = 3.5–5), calcium 8.2 mg/dl (N = 8.8–
10.8), blood urea nitrogen (BUN) 48.5 mg/dl (N = 5–18), creati-
nine 2 mg/dl (N = 0.3–0.7), albumin 2.8 g/dl (N = 3.9–5.3). Serum
transaminases, C-reactive protein, erythrocyte sedimentation
rate and coagulation parameters were normal. Urine analysis
revealed hematuria and moderate proteinuria (26 mg/m2/h).Fig. 1 – (a and b) Axial and sagittal magnetic resonance fluid att
increased signal within the cortex and subcortical white matter
bilateral cerebellar hemispheres.Diagnosis of IgAV and nephritis has been made based on these
ﬁndings. To rule out other vasculitis, the serum C3 and C4
levels were normal; ANA, anti-dsDNA, p-ANCA, and c-ANCA
were also negative. For arthritis, a non-steroid anti-inﬂamma-
tory agent was given. The impairment in renal function tests
improved via liquid treatment in ﬁrst two days. Stomachache
became intensiﬁed, and gastrointestinal system hemorrhage
developed, so 1 mg/kg/day dose of oral prednisolone treat-
ment was started. In 3rd day of treatment, chest pain and sinus
bradycardia developed. Cardiological examinations and echo-
cardiography were normal.
In 7th day of prednisolone treatment, subconjuctival
hemorrhage and severe headache then after sudden visual
loss have developed. His level of consciousness was normal
but mild pretibial edema has been occurred. In neurological
examination, there was no neck stiffness or positive signs of
meningeal irritation; motor and sensorial examination were
normal, deep tendon reﬂexes were normoactive. Pupil reﬂexes
were normal but visual acuity was deteriorated. Fundus
examination has revealed mild attenuation of optic disk
borders, bilaterally. His blood pressure was 150/90 mmHg, so
an angiotensin converting enzyme inhibitor (ramipril) was
given for hypertension. In brain CT, hypodense visuals were
observed in subcortical region of bilateral parietooccipital and
cerebellar hemisphere lobes. Cranial MRI was taken for lesion
exclusion, and demonstrated hyperintense regions that
observed in T2 and FLAIR sequences in corpus collosum
splenium, subcortical regions in parieto-occipital lobes and
bilateral cerebellar hemispheres (Fig. 1a and b). There were
restrictions in diffusion MRI, and hyperintense visual in
apparent diffusion coefﬁcient (ADC) images. These ﬁndings
indicated a diagnosis of PRES developing as a result of IgAV
(Fig. 2a and b).
Due to the diagnosis of PRES, intravenous methylpredniso-
lone with dose of 30 mg/kg/day was started. Impairment of
vision resolved immediately after treatment, and proteinuria
with hypoalbuminemia was gradually improved. Steroid and
antihypertensive therapy were given after discharge. Follow-
up MRI after two months was revealed complete resolution of
previous ﬁndings. Renal function tests and urine analysis were
also normal in follow-up period. In control MRI examinationenuated inversion recovery images demonstrate bilateral
 of the parietal and occipital lobes. Lesions also are seen in
Fig. 2 – (a–c) Axial diffusion-weighted images revealed restricted diffusivity within these areas of signal change and hyper-
intense signals on apparent diffusion coefficient images.
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after 2 months, it has been seen that lesions were disappeared
(Fig. 3a and b).
3. Discussion
The pathogenesis of IgAV is not completely understood. It is a
leukocytoclastic vasculitis which is a consequence of sub-
endothelial storage of IgA (only IgA1 subclass) immune
complexes in small arteries and capillaries. Therefore, IgAV
was commonly seen after various viral and bacterial infections
[1,2]. But, generally the exact etiology was remaining unde-
tected in most cases, as in our patient.
Renal manifestations in IgAV are reported to be 10–50%
and include, microscopic hematuria and/or proteinuria in
most cases, nephritis or nephrotic syndrome (20%) and
end-stage renal disease [2]. Garzoni et al. reported that
severe renal involvement was the most common (29 of
54 patients) concomitant feature in IgAV patients with
neurological dysfunction which indicating close correla-
tion between severity of renal disease and neurological
features [8].Fig. 3 – (a and b) Axial magnetic resonance fluid attenuated inve
show resolution of cerebral lesions.Neurological dysfunctions with or without severe hyper-
tension have been documented in IgAV. Headache is reported
as the commonest and other central and/or peripheral nervous
system manifestations include seizures, peripheral neuropa-
thies, chorea, ataxia, aphasia, blindness, coma, EEG abnor-
malities, intracerebral hemorrhage and infarcts [2,8]. The
incidence is unknown but they have been reported in 1–8% of
all IgAV patients [2,8]. In addition, a few PRES cases have also
been identiﬁed with IgAV [3,9–12]. It has been suggested that,
immune complex deposition could lead arteriolar inﬂamma-
tion in the cerebral circulation [12]. On the other hand, renal
failure, hypertension, electrolyte imbalance or other concur-
rent conditions could also contribute pathogenesis of neuro-
logical involvement [12].
PRES is a clinic-radiologic entity developing with vasogenic
edema characterized by generally bilateral hyperintense
signals in T2 and FLAIR images on posterior parietal and
occipital lobes [3]. The hyperfusion theory is the most
commonly approved pathogenetic mechanism. Brieﬂy, causes
of PRES (e.g. sudden increase of blood pressure) can induce
breakdown in cerebral autoregulation, and as a result, leakage
of ﬂuid into the brain parenchyma has been occurred [3]. Due
to the slight control of sympathetic system in posteriorrsion recovery images performed 2 months after admission
Table 1 – Clinical and radiologic features of patients from literature with PRES in association with IgAV.




BP (mmHg) Lab (urine analysis
and RFT)
References
7/F Bilateral HWML in the occipital
and posterior parietal
GTCC, LOV 190/100 Normal Fuchigami et al. [10]
11/F Bilateral HWML in the






115/82 Normal Dasarathi et al. [11]
10/M Bilateral HWML in the occipital
and posterior parietal
Convulsions 130/90 Normal Özçakar et al. [7]
13/F Bilateral HS in the cerebellum,




180/120 Grade V HSP nephritis Sasayama et al. [9]
10/M Bilateral HS in the parieto-
occipital cortical and white
matter
LOV, headache Normal Hyponatremia
(126 mmol/L)
Woolfenden et al. [12]
11/M Focal lesion in the white and gray
matter of the left occipital
GTCC 150/85 Normal Pavlou et al. [14]




170/115 Normal Khandhar et al. [15]
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regions [3,13]. Endothelial dysfunction due to infectious,
cytotoxic and immune causes is other possible mechanism
[3,5].
In PRES, the signal intensity of lesion is either lower or
normal on diffusion-weighted images (DWI), in contrast to
cytotoxic edema (high signal in DWI) which is an indicator of
acute cerebral infarct. In addition, signal intensity observed on
ADC (apparent diffusion coefﬁcient) maps which eliminating
the signal effect of T2, is increased while it is low in cytotoxic
edema. Although, vasogenic and cytotoxic edemas could seen
together and also vasogenic edema can progress to cytotoxic
edema, in general, PRES thought to be occurred due to
vasogenic edema [3–5,13]. Another difference was that PRES
resolves completely after treatment, rather than seen in
cytotoxic edema. These features are used to distinguish PRES
from ischemic processes such as bilateral posterior lob infarcts
and others including cerebral venous thrombosis, viral
encephalitis, mitochondrial encephalopathy, hypoglycemia
and hyponatremia [3–5].
Hinchey et al. (only adults) and Endo et al. (only children)
were reviewed PRES cases due to various causes and reported
involving both cortical and subcortical of parieto-occipital,
frontal, temporal and cerebellar involvement rate as 93% vs
89.1%, 40% vs 17.4%, 60% vs 17.4% and 6% vs 21.7%, respectively
[3,6]. We could identify 7 pediatric case with PRES in
association with IgAV in literature. The localizations of lesions
are summarized in Table 1. These data present only PRES
cases, not vasculitis.
In our case, BP was in normal ranges on admission but it
has been increased to 150/90 mmHg level when neurological
signs have occurred. According to normograms by age and
height in Turkish children, he had a systolic BP above 99th
percentile (143 mmHg) and a diastolic BP between 90 and 95th
percentile (85–95 mmHg) [16]. Thus, he considered as a slightly
hypertensive patient. Most of the children had severe
hypertension in previous reports of PRES cases with IgAV.While, Woolfenden et al. and Dasarathi et al. have found
radiologic features of PRES without hypertension [11,12].
However, it was difﬁcult to establish the exact cause of PRES
in our case, because of positive fundus examination, absence
of convulsion or focal neurological deﬁcit, presence of
proteinuria and impaired renal functions, the vasogenic
pattern of edema and reversible features in neuroimaging
by treatment, we determined that our ﬁndings as consistent
with hypertension. Diagnosis and differentiation of PRES and
secondary cerebral vasculitis in IgAV, said to be difﬁcult due to
collective attribution of hypertensive or uremic encephalopa-
thy, metabolic disorders, electrolyte imbalance, impairment in
auto-regulatory mechanism of cerebral circulation or side
effects of steroid therapy [5,10,12,15]. To rule out possible
cerebral vasculitis, we did not perform magnetic resonance
angiography due to rapid clinical improvement after treat-
ment.
Few data exists concerning treatment of neurologic
complications in IgAV. Garzoni et al. suggested that manage-
ment might include control of hypertension, convulsions and
repair of disordered hemostasis with preferably use of steroids
and cyclophosphamide for cerebral vasculitis [8]. Early
diagnosis of PRES is important, otherwise the clinic situation
may advance to ischemia, massive infarct, and even death.
In conclusion, PRES and other severe neurological mani-
festations can be seen in association with IgAV, the most
common vasculitis in childhood. When clinical and radiologic
collaboration and follow-up of the disease achieved, PRES can
be diagnosed in most cases. Since, delay in the diagnosis and
treatment can lead severe damage to CNS and even mortality,
this rare complication must be kept in mind in daily practice.
Neuroimaging investigations which including diffusion imag-
ing and angiography can give crucial contribution to clinicians
for prompt diagnosis. Detailed clinical information and other
data of patient will also help the radiologists in evaluating
PRES and other entities that can manifest similar ﬁndings in
neuroimaging.
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